Endo International plc is a generics and specialty branded pharmaceutical company. It was created as a result of a management buyout from DuPont Merck in 1997 led by Carol 2009, Endo bought Indevus Pharmaceuticals to diversify into endocrinology and oncology. The company entered the male hypogonadism market later in 2010 with Fortesta 2% November 2013, Endo agreed to purchase Paladin Labs Inc for about $ billion to gain access to the Canadian market as well as expand into emerging October 2014, Endo said it would buy Auxilium Pharmaceuticals for $ 2015, Endo acquired the specialty generics and sterile injectables company Par Pharmaceutical for $ attemptsIn early 2014, Endo sought to acquire NuPathe, a speciality pharmaceutical developer, for $105 million. However, Teva prevailed in this acquisition with a substantially higher is one of the companies named in lawsuits by the states of Ohio, Missouri and Mississippi as responsible for the US opioid epidemic. Its 10-K statement indicates that a majority of the company's US revenue in 2016 was derived from the sale of prescription pain killers, predominantly Also Opioid epidemic
"Endo Pharmaceuticals Solutions Inc" - Social Networks
Do you own or manage this business? Click here to claim the Endo Pharmaceuticals Solutions Inc listing and add social networks, logos, descriptions and more.
Please enter your phone number and click "Send" to receive the listing details by SMS.
For numbers outside the US, please enter the country code, for e.g. +91.
If you do not receive a message, your phone number might be registered in the Do Not Disturb Registry.
Number:
For numbers outside the US please enter the country code.
Please enter your phone number and click "Call" to call the listing owner.
Number:
For numbers outside the US please enter the country code.
